CTC Alternative Strategies’s Merck MRK Stock Holding History

CTC Alternative Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Buy	+1,900	New	+$222K	0.35%	65
2025 Q3	–	Sell	-39,320	Closed	-$3.11M	–	154
2025 Q2	$3.11M	Buy	+39,320	New	+$3.13M	2.72%	9
2024 Q4	–	Sell	-1,976	Closed	-$224K	–	75
2024 Q3	$224K	Buy	+1,976	New	+$235K	0.28%	46
2023 Q3	–	Sell	-2,050	Closed	-$237K	–	148
2023 Q2	$237K	Buy	+2,050	New	+$233K	0.29%	107
2014 Q3	–	Sell	-10,375	Closed	-$573K	–	167
2014 Q2	$573K	Buy	+10,375	New	+$566K	0.48%	44
2013 Q4	–	Sell	-11,191	Closed	-$508K	–	165
2013 Q3	$508K	Buy	+11,191	New	+$511K	0.78%	14

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CTC Alternative Strategies's MRK Position: Q2 2026 in Review

CTC Alternative Strategies opened a new position in Merck (MRK) in Q2 2026: 1,900 shares worth $244K. The stake represents 0.35% of the portfolio and ranks #65 among its holdings. This is a return to the name: CTC Alternative Strategies previously reported a position in MRK as recently as Q2 2025.

CTC Alternative Strategies first reported a position in MRK in Q3 2013 and has held it in 6 quarters since. The position peaked at $3.11M in Q2 2025. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

CTC Alternative Strategies held 1,900 shares of Merck worth $244K as of Q2 2026.
Merck was a new CTC Alternative Strategies position in Q2 2026.
Merck made up 0.35% of CTC Alternative Strategies's portfolio in Q2 2026, its #65 holding.
CTC Alternative Strategies first reported a position in Merck in Q3 2013 and has held it in 6 quarters since.
CTC Alternative Strategies's Merck position peaked at $3.11M in Q2 2025.
3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CTC Alternative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.